Thromboprophylaxis in Extracorporeal Circuits: Current Pharmacological Strategies and Future Directions
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Cardiovascular Drugs"
DOI: 10.1007/s40256-017-0229-0
Abstract: AbstractThe development of extracorporeal devices for organ support has been a part of medical history and progression since the late 1900s. These types of technology are primarily used and developed in the field of critical… read more here.
Keywords: anticoagulation; extracorporeal circuits; thromboprophylaxis extracorporeal; circuits current ... See more keywords
Current pharmacological solutions for Behçet’s syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2155047
Abstract: ABSTRACT Introduction Behçet’s syndrome (BS) has a heterogeneous clinical phenotype, and its clinical manifestations may respond differently to drugs commonly used to treat BS. The type, dose, and duration of immunomodulatory, immunosuppressive, and biologic agents… read more here.
Keywords: current pharmacological; solutions beh; pharmacological solutions; management ... See more keywords
Current Pharmacological Treatment of Type 2 Diabetes Mellitus in Undocumented Migrants: Is It Appropriate for the Phenotype of the Disease?
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph17218169
Abstract: Type 2 diabetes is increasingly recognized as a spectrum of metabolic disorders sharing chronic hyperglycaemia. In Europe, the continually growing number of migrants from developing countries could affect diabetes phenotypes. We evaluated a population of… read more here.
Keywords: pharmacological treatment; type diabetes; current pharmacological; undocumented migrants ... See more keywords